細胞・遺伝子治療用器具と試薬の世界市場:2027年までに137億ドル規模へ

出版:BCC Research(BCCリサーチ) 出版年月:2022年10月

Cell and Gene Therapy Tools and Reagents: Global Markets
細胞・遺伝子治療用器具と試薬の世界市場:2027年までに137億ドル規模へ

ページ数 139
価格
 シングルユーザライセンス USD 5,500
 2-5ユーザライセンス USD 6,600
 サイトライセンス USD 7,920
 エンタープライズライセンス USD 9,504
種別 英文調査報告書

レポート目次  お問合せ・ご注文  価格・納期について

無料サンプル

BCC Research(BCCリサーチ)「細胞・遺伝子治療用器具と試薬の世界市場:2027年までに137億ドル規模へ – Cell and Gene Therapy Tools and Reagents: Global Markets」は細胞治療および遺伝子治療向け器具と試薬市場を調査し、主要セグメント毎に行った分析・予測結果を提供します。

主な対象セグメント

  • 用途
    • がん
    • 希少疾病
    • その他の疾病
  • エンドユーザ
    • バイオテクノロジー企業および製薬会社
    • 学術および調査機関
    • 臨床検査室/病院
  • タイプ
    • GMPプロテイン
    • 媒体
    • 細胞分離
    • 細胞増殖
    • ベクター
    • GMP小分子
    • GMP抗体
    • 白血球除去輸血
    • 凍結保存
    • バイオリアクター
    • イムノアッセイとマルチプレックスイムノアッセイ
    • サイトカイン放出試験
  • 地域
    • 北米
    • 欧州
    • アジア太平洋地域
    • その他の地域(RoW)

主な掲載内容

  1. 概説
  2. サマリー&ハイライト
  3. 市場および技術背景
  4. 市場ダイナミクス
  5. 市場ブレイクダウン:用途
  6. 市場ブレイクダウン:エンドユーザ
  7. 市場ブレイクダウン:タイプ
  8. 市場ブレイクダウン:地域
  9. 政府規制
  10. 特許レビュー/新規開発
  11. 競争環境
  12. 企業情報

Report Highlights

The global market for cell and gene therapy tools and reagents is estimated to grow from $8.3 billion in 2022 to $13.7 billion in 2027, with a compound annual growth rate (CAGR) of 10.6% for the period of 2022-2027.

Summary:

Cell and gene therapies (CGT) are a novel therapeutic modality for a range of chronic and age-related conditions. These provide a fundamental treatment option for disease conditions that do not have a cure or cannot be treated with conventional drugs. Initially, cell and gene therapies were highly explored for oncology. However, the research is expanding into other areas including autoimmune disease, rare disease, musculoskeletal disease, cardiovascular disease and dermatological diseases. Cell and gene therapy has potential applications in many disease areas, including cancers, autoimmune diseases, urinary disorders, spinal cord injuries, type I diabetes, Parkinson’s disease, Alzheimer’s disease, heart disease, stroke, burns and osteoarthritis.

Demand for cell and gene therapies is high and there is lot of R&D in this segment supported by huge investments and funding for CGTs.

Increasing investments, capacity expansions for clinical and commercial manufacturing, increasing prevalence of chronic diseases and increased healthcare expenditure drive the cell and gene therapy tools and reagents market. There have been accelerated approvals in recent years coupled with technological advancements (development of off-the-shelf products and application of advanced gene editing techniques like CRISPR) will lower the complexities involved around manufacturing CGTs and will attract many pharma and biotech companies to enter the market.

The cell and gene therapy tools and reagents market is segmented based on application, type, end user and region. Major players in the market are Thermo Fisher, Merck KGaA, Cytiva, Miltenyi Biotech, Sartorius and Bio-Rad Laboratories.

The North American region has the highest share, followed by Europe. Extensive R&D activities take place in the region, there are major players present, plentiful funding and increasing prevalence of chronic diseases. All these factors contribute to growth in the market. Based on application, the cancer segment has the highest share.

Report Scope:

The scope of this study encompasses an investigation of cell and gene therapy tools: GMP proteins, media, cell separation and activation reagents, viral and non-viral, cytokine release syndrome monitoring products, GMP antibodies, leukapheresis instrumentation, immunoassays (multiplex and singleplex) and bioreactors. BCC Research analyzes each tool type, determines its current market status, examines its impact on future markets and presents forecasts of growth over the next six years. The current report provides detailed analysis of the market’s drivers, challenges and opportunities. The report also covers market projections to 2027 and market share for key market players. The report includes the company profiles of key players with detailed information about business segments, financials, product portfolios and recent developments. The report provides impact analysis of the COVID-19 pandemic on this market.

Report Includes:

– 105 total tables
– An updated overview of the global market for immunoassay-based cell and gene therapy tools and reagents
– Analyses of the global market trends, with historic market revenue for 2019-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
– Highlights of the market potential for the cell and gene therapy tools and reagents in the life sciences industry, growth driving factors, and areas of focus to forecast this market into various segments and sub-segments
– Estimation of actual market size and revenue forecast for cell and gene therapy tools and reagents in USD million terms, and corresponding market share analysis based on product, application/disease area, end-user, and region
– In-depth information (facts and figures) concerning major market dynamics (DROs), product innovations, clinical trials, and various government regulations affecting the market outlook for cell and gene therapy tools and reagents
– Review of prevalence of infectious disease, metabolic disorders and chronic ailments; along with the recent technological advancements, competitive environment, and the industry value chain analysis
– Coverage of the technological, economic, and business considerations of the prevailing cell and gene therapy tools market, and its vendor landscape
– Patent review and new developments, R&D efforts, industrial changes with emphasis on recent investments, and current state of the immunoassay technology
– Identification of the companies best positioned to meet the demand for cell and gene therapy in life sciences applications owing to their proprietary technologies, novel product launches, key mergers and acquisition deals, and other strategic advantages
– Descriptive company profiles of the market leading players, including Abcam, Akron Biotech, Adverum Biotechnologies and Avrobio.


目次

Table of Contents

Chapter 1 Introduction

1.1 Study Goals and Objectives
1.2 Reasons for Doing This Study
1.3 Scope of Report
1.4 What’s New in This Update?
1.5 Information Sources
1.6 Methodology
1.7 Geographic Breakdown
1.8 Analyst’s Credentials
1.9 BCC Custom Research
1.10 Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

3.1 Overview: Cell and Gene Therapy
3.1.1 Cell Therapy
3.1.2 Gene Therapy
3.2 Types of Cell and Gene Therapy
3.2.1 Gene Therapy
3.2.2 Cell Therapy
3.2.3 Evolution and Expansion of Therapies
3.2.4 Common Equipment Used

Chapter 4 Market Dynamics

4.1 Factors Affecting the Market
4.2 Market Drivers
4.2.1 Increasing Investment in CGT R&D
4.2.2 Capacity Expansions for Clinical and Commercial Manufacturing
4.2.3 Increasing Incidence of Chronic Diseases
4.2.4 Increasing Strategic Collaborations and Acquisitions
4.2.5 Market Restraints
4.2.6 Complex Manufacturing and Supply Chain
4.2.7 Lack of Skilled Workforce
4.2.8 Market Opportunities
4.3 Impact of COVID-19

Chapter 5 Market Breakdown, by Application

5.1 Cell and Gene Therapy Tools and Reagents Market
5.2 Cancer
5.3 Rare Diseases
5.4 Other Diseases

Chapter 6 Market Breakdown, by End User

6.1 Biotechnology and Pharmaceutical Companies
6.2 Academic and Research Institutes
6.3 Clinical Laboratories/Hospitals
6.4 GMP Proteins

Chapter 7 Market Breakdown, by Type

7.1 GMP Proteins

7.1.1 GMP Proteins by Application
7.1.2 GMP Proteins, by End User

7.2 Media

7.2.1 Media by Application
7.2.2 Media by End User

7.3 Cell Separation

7.3.1 Cell-Separation by Application
7.3.2 Cell Separation by End User

7.4 Cell Expansion

7.4.1 Cell Expansion by Application
7.4.2 Cell Expansion by End User

7.5 Vectors

7.5.1 Vectors by Application
7.5.2 Vectors, by End User

7.6 GMP Small Molecules

7.6.1GMP Small Molecules by Application
7.6.2 GMP Small Molecules, by End User

7.7 GMP Antibodies

7.7.1 GMP Antibodies, by Application
7.7.2 GMP Antibodies, by End User

7.8 Leukapheresis

7.8.1 Leukapheresis, by Application
7.8.2 Leukapheresis by End User

7.9 Cryopreservation

7.9.1 Cryopreservation, by Application
7.9.2 Cryopreservation by End User

7.10 Bioreactors

7.10.1 Bioreactors, by Application
7.10.2 Bioreactors, by End User

7.11 Immunoassays and Multiplex Immunoassays

7.11.1 Immunoassays, by Application
7.11.2 Immunoassays, by End User
7.11.3 Multiplex Immunoassays, by Application
7.11.4 Multiplex Immunoassays, by End User

7.12 Cytokine Release Testing

7.12.1 Cytokine Release Testing, by Application
7.12.2 Cytokine Release Testing by End User

Chapter 8 Market Breakdown by Region

8.1 North America
8.2 Europe
8.3 Asia-Pacific
8.4 Rest of the World

Chapter 9 Government Regulations

9.1 Scope of Regulations on Gene Therapy
9.1.1 Viral and Non-Viral Vectors
9.1.2 Media
9.1.3 GMP Proteins and Antibodies
9.1.4 Cell Therapy
9.1.5 Leukapheresis
9.1.6 Cell Therapy, Gene Therapy and the EMA

Chapter 10 Patent Review/New Developments

10.1 Cell and Gene Therapy R&D
10.1.1 Academia
10.2 Technology
10.2.1 Key Patents

Chapter 11 Competitive Landscape

11.1 Mergers and Acquisitions
11.1.1 Strategic Initiatives
11.2 Competitive Analysis

Chapter 12 Company Profiles

ABCAM
AKRON BIOTECH
ADVERUM BIOTECHNOLOGIES
ATHERSYS INC.
AVROBIO
BIO-RAD LABORATORIES
BIO-TECHNE
CELLGENIX
CYTIVA LIFE SCIENCES
FUJIFILM IRVINE SCIENTIFIC
LUMINEX CORP.
MESOBLAST LTD.
MERCK KGAA
MILTENYI BIOTEC
ORGANICELL
PROTEINTECH GROUP INC.
SARTORIUS
SINO BIOLOGICAL INC.
STEMCELL TECHNOLOGIES
THERMO FISHER SCIENTIFIC

List of Tables

Summary Table A : Global Market for Cell and Gene Therapy Tools and Reagents, Through 2027
Summary Table B : Global Market for Cell and Gene Therapy Tools and Reagents, by Region, Through 2027
Table 1 : Global Cancer Statistics, 2020
Table 2 : Global Market for Cell and Gene Therapy Tools and Reagents, Through 2027
Table 3 : Global Cell and Gene Therapy Tools and Reagents Market, by Application, Through 2027
Table 4 : Global Cell and Gene Therapy Tools and Reagents Market for Cancer, by Region, Through 2027
Table 5 : Global Cell and Gene Therapy Tools and Reagents for Rare Diseases, by Region, Through 2027
Table 6 : Global Cell and Gene Therapy Tools and Reagents for Other Diseases, by Region, Through 2027
Table 7 : Global Cell and Gene Therapy Tools and Reagents Market, by End User, Through 2027
Table 8 : Global Cell and Gene Therapy Tools and Reagents for Pharmaceutical and Biotechnology Companies, by Region, Through 2027
Table 9 : Global Cell and Gene Therapy Tools and Reagents Market for Academic and Research Institutes, by Region, Through 2027
Table 10 : Global Cell and Gene Therapy Tools and Reagents Market for Clinical Laboratories, by Region, Through 2027
Table 11 : Global Cell and Gene Therapy Tools and Reagents Market, by Type, Through 2027
Table 12 : Global Market for GMP Proteins, by Region, Through 2027
Table 13 : Global Market for GMP Proteins for Cancer, by Region, Through 2027
Table 14 : Global Market for GMP Proteins for Rare Diseases, by Region, Through 2027
Table 15 : Global Market for GMP Proteins for Other Diseases, by Region, Through 2027
Table 16 : Global Market for GMP Proteins for Pharmaceutical and Biotechnology Companies, by Region, Through 2027
Table 17 : Global Market for GMP Proteins for Academic and Research Institutes, by Region, Through 2027
Table 18 : Global Market for GMP Proteins for Clinical Laboratories and Hospitals, by Region, Through 2027
Table 19 : Global Market for Media, by Region, Through 2027
Table 20 : Global Market for Cancer Media, by Region, Through 2027
Table 21 : Global Market for Media for Rare Diseases, by Region, Through 2027
Table 22 : Global Market for Media for Other Diseases, by Region, Through 2027
Table 23 : Global Market for Media for Pharmaceutical and Biotechnology Companies, by Region, Through 2027
Table 24 : Global Market for Media for Academic and Research Institutes, by Region, Through 2027
Table 25 : Global Market for Clinical Laboratory and Hospital Media, by Region, Through 2027
Table 26 : Global Market for Cell Separation, by Region, Through 2027
Table 27 : Global Market for Cancer Cell Separation, by Region, Through 2027
Table 28 : Global Market for Rare Disease Cell Separation, by Region, Through 2027
Table 29 : Global Market for Cell Separation for Other Diseases, by Region, Through 2027
Table 30 : Global Market for Cell Separation, Pharmaceutical and Biotechnology Companies, by Region, Through 2027
Table 31 : Global Market for Cell Separation, Academic and Research Institutes, by Region, Through 2027
Table 32 : Global Market for Cell Separation, Clinical Laboratories and Hospitals, by Region, Through 2027
Table 33 : Global Market for Cell Expansion, by Region, Through 2027
Table 34 : Global Market for Cell Expansion for Cancer, by Region, Through 2027
Table 35 : Global Market for Cell Expansion for Rare Diseases, by Region, Through 2027
Table 36 : Global Market for Cell Expansion for Other Diseases, by Region, Through 2027
Table 37 : Global Market for Cell Expansion for Pharmaceutical and Biotechnology Companies, by Region, Through 2027
Table 38 : Global Market for Cell Expansion, Academic and Research Institutes, by Region, Through 2027
Table 39 : Global Market for Cell Expansion for Clinical Laboratories and Hospitals, by Region, Through 2027
Table 40 : Global Market for Vectors, by Region, Through 2027
Table 41 : Global Market for Cancer Vectors, by Region, Through 2027
Table 42 : Global Market for Rare Disease Vectors, by Region, Through 2027
Table 43 : Global Market for Vectors for Other Diseases, by Region, Through 2027
Table 44 : Global Market for Vectors for Pharmaceutical and Biotechnology Companies, by Region, Through 2027
Table 45 : Global Market for Vectors for Academic and Research Institutes, by Region, Through 2027
Table 46 : Global Market for Vectors for Clinical Laboratories and Hospitals, by Region, Through 2027
Table 47 : Global Market for GMP Small Molecules, by Region, Through 2027
Table 48 : Global Market for GMP Small Molecules for Cancer, by Region, Through 2027
Table 49 : Global Market for GMP Small Molecules for Rare Diseases, by Region, Through 2027
Table 50 : Global Market for GMP Small Molecules for Other Diseases, by Region, Through 2027
Table 51 : Global Market for GMP Small Molecules for Pharmaceutical and Biotechnology Companies, by Region, Through 2027
Table 52 : Global Market for GMP Small Molecules for Academic and Research Institutes, by Region, Through 2027
Table 53 : Global Market for GMP Small Molecules for Clinical Laboratories and Hospitals, by Region, Through 2027
Table 54 : Global Market for GMP Antibodies, by Region, Through 2027
Table 55 : Global Market for GMP Antibodies for Cancer, by Region, Through 2027
Table 56 : Global Market for GMP Antibodies for Rare Diseases, by Region, Through 2027
Table 57 : Global Market for GMP Antibodies for Other Diseases, by Region, Through 2027
Table 58 : Global Market for GMP Antibodies for Pharmaceutical and Biotechnology Companies, by Region, Through 2027
Table 59 : Global Market for GMP Antibodies for Academic and Research Institutes, by Region, Through 2027
Table 60 : Global Market for GMP Antibodies for Clinical Laboratories and Hospitals, by Region, Through 2027
Table 61 : Global Market for Leukapheresis, by Region, Through 2027
Table 62 : Global Market for Leukapheresis for Cancer, by Region, Through 2027
Table 63 : Global Market for Leukapheresis for Rare Diseases, by Region, Through 2027
Table 64 : Global Market for Leukapheresis for Other Diseases, by Region, Through 2027
Table 65 : Global Market for Leukapheresis for Pharmaceutical and Biotechnology Companies, by Region, Through 2027
Table 66 : Global Market for Leukapheresis for Academic and Research Institutes, by Region, Through 2027
Table 67 : Global Market for Leukapheresis for Clinical Laboratories and Hospitals, by Region, Through 2027
Table 68 : Global Market for Cryopreservation, by Region, Through 2027
Table 69 : Global Market for Cryopreservation for Cancer, by Region, Through 2027
Table 70 : Global Market for Cryopreservation for Rare Diseases, by Region, Through 2027
Table 71 : Global Market for Cryopreservation for Other Diseases, by Region, Through 2027
Table 72 : Global Market for Cryopreservation for Pharmaceutical and Biotechnology Companies, by Region, Through 2027
Table 73 : Global Market for Cryopreservation for Academic and Research Institutes, by Region, Through 2027
Table 74 : Global Market for Cryopreservation for Clinical Laboratories and Hospitals, by Region, Through 2027
Table 75 : Global Market for Bioreactors, by Region, Through 2027
Table 76 : Global Market for Bioreactors for Cancer, by Region, Through 2027
Table 77 : Global Market for Bioreactors for Rare Diseases, by Region, Through 2027
Table 78 : Global Market for Bioreactors for Other Diseases, by Region, Through 2027
Table 79 : Global Market for Bioreactors for Pharmaceutical & Biotechnology Companies, by Region, Through 2027
Table 80 : Global Market for Bioreactors for Academic and Research Institutes, by Region, Through 2027
Table 81 : Global Market for Bioreactors for Clinical Laboratories and Hospitals, by Region, Through 2027
Table 82 : Global Market for Research-Use-Only Immunoassays, by Region, Through 2027
Table 83 : Global Market for Research-Use-Only Multiplex Immunoassays, by Region, Through 2027
Table 84 : Global Market for Research-Use-Only Immunoassays for Cancer, by Region, Through 2027
Table 85 : Global Market for Research-Use-Only Immunoassays for Rare Diseases, by Region, Through 2027
Table 86 : Global Market for Research-Use-Only Immunoassays for Other Diseases, by Region, Through 2027
Table 87 : Global Market for Research-Use-Only Immunoassays for Pharmaceutical and Biotechnology Companies, by Region, Through 2027
Table 88 : Global Market for Research-Use-Only Immunoassays for Academic and Research Institutes, by Region, Through 2027
Table 89 : Global Market for Research-Use-Only Immunoassays for Clinical Laboratories and Hospitals, by Region, Through 2027
Table 90 : Global Market for Research-Use-Only Multiplex Immunoassays for Cancer, by Region, Through 2027
Table 91 : Global Market for Research-Use-Only Multiplex Immunoassays for Rare Diseases, by Region, Through 2027
Table 92 : Global Market for Research-Use-Only Multiplex Immunoassays for Other Diseases, by Region, Through 2027
Table 93 : Global Market for Research-Use-Only Multiplex Immunoassays for Pharmaceutical and Biotechnology Companies, by Region, Through 2027
Table 94 : Global Market for Research-Use-Only Multiplex Immunoassays for Academic and Research Institutes, by Region, Through 2027
Table 95 : Global Market for Research-Use-Only Multiplex Immunoassays for Clinical Laboratories and Hospitals, by Region, Through 2027
Table 96 : Global Market for Cytokine Release Testing, by Region, Through 2027
Table 97 : Global Market for Cytokine Release Testing for Cancer, by Region, Through 2027
Table 98 : Global Market for Cytokine Release Testing for Rare Diseases, by Region, Through 2027
Table 99 : Global Market for Cytokine Release Testing for Other Diseases, by Region, Through 2027
Table 100 : Global Market for Cytokine Release Testing for Pharmaceutical and Biotechnology Companies, by Region, Through 2027
Table 101 : Global Market for Cytokine Release Testing for Academic and Research Institutes, by Region, Through 2027
Table 102 : Global Market for Cytokine Release Testing for Clinical Laboratories and Hospitals, by Region, Through 2027
Table 103 : Global Cell and Gene Therapy Tools and Reagents Market, by Region, Through 2027
Table 104 : Mergers and Acquisitions, 2020-2022
Table 105 : Competitive Analysis: Cell and Gene Therapy Tools and Reagents Market, 2021

List of Figures
Summary Figure A : Global Market for Cell and Gene Therapy Tools and Reagents, 2019-2027
Summary Figure B : Global Market for Cell and Gene Therapy Tools and Reagents, by Region, 2019-2027
Figure 1 : Global Cell and Gene Therapy Tools and Reagents Market, by Application, 2019-2027
Figure 2 : Global Cell and Gene Therapy Tools and Reagents, by Application, 2021
Figure 3 : Global Cell and Gene Therapy Tools and Reagents for Cancer, by Region, 2019-2027
Figure 4 : Global Cell and Gene Therapy Tools and Reagents for Rare Diseases, by Region, 2019-2027
Figure 5 : Global Cell and Gene Therapy Tools and Reagents for Other Diseases, by Region, 2019-2027
Figure 6 : Global Cell and Gene Therapy Tools and Reagents, by End User, 2019-2027
Figure 7 : Global Cell and Gene Therapy Tools and Reagents, by End User, 2021
Figure 8 : Private Investment, Cell and Gene Therapy, 2014-2021
Figure 9 : Global Cell and Gene Therapy Tools and Reagents for Pharmaceutical and Biotechnology Companies, by Region, 2019-2027
Figure 10 : Global Cell and Gene Therapy Tools and Reagents Market for Academic and Research Institutes, by Region, 2019-2027
Figure 11 : Global Cell and Gene Therapy Tools and Reagents Market for Clinical Laboratories, by Region, 2019-2027
Figure 12 : Global Cell and Gene Therapy Tools and Reagents Market, by Type, 2019-2027
Figure 13 : Global Cell and Gene Therapy Tools and Reagents Market, by Type, 2021
Figure 14 : Global Market for GMP Proteins, by Region, 2019-2027
Figure 15 : Global Market for Media, by Region, 2019-2027
Figure 16 : Global Market for Cell Separation, by Region, 2019-2027
Figure 17 : Global Market for Cell Expansion, by Region, 2019-2027
Figure 18 : Vectors Used in Gene Therapy Clinical Trials, 2018
Figure 19 : Global Market for Vectors, by Region, 2019-2027
Figure 20 : Global Market for GMP Small Molecules, by Region, 2019-2027
Figure 21 : Global Market for GMP Antibodies, by Region, 2019-2027
Figure 22 : Global Market for Leukapheresis, by Region, 2019-2027
Figure 23 : Global Market for Cryopreservation, by Region, 2019-2027
Figure 24 : Global Market for Bioreactors, by Region, 2019-2027
Figure 25 : Global Market for Research-Use-Only Immunoassays, by Region, 2019-2027
Figure 26 : Global Market for Research-Use-Only Multiplex Immunoassays, by Region, 2019-2027
Figure 27 : Global Market for Cytokine Release Testing, by Region, 2019-2027
Figure 28 : Global Cell and Gene Therapy Tools and Reagents Market, by Region, 2019-2027
Figure 29 : Global Cell and Gene Therapy Tools and Reagents Market, by Region, 2021
Figure 30 : U.S. Market for Cell and Gene Therapy Tools and Reagents, 2019-2027
Figure 31 : China Market for Cell and Gene Therapy Tools and Reagents, 2019-2027
Figure 32 : Bio-Rad Laboratories Inc.: Annual Revenue, 2019-2021
Figure 33 : Bio-Rad Laboratories Inc.: Market Share, by Business Segment, 2021
Figure 34 : Bio-Rad Laboratories Inc.: Revenue Share, by Region/Country, 2021
Figure 35 : Bio-Techne: Annual Revenue, 2019-2021
Figure 36 : Bio-Techne: Market Share, by Business Segment, 2021
Figure 37 : Bio-Techne: Revenue Share, by Region/Country, 2021
Figure 38 : Danaher Life Science Segment (including Cytiva): Annual Revenue, 2019-2021
Figure 39 : Danaher Life Sciences Segment (Including Cytiva): Market Share, by Region, 2021
Figure 40 : Merck KGaA Life Sciences Segment: Annual Revenue, 2019-2021
Figure 41 : Merck KGaA Life Sciences Segment: Revenue, by Region, 2021
Figure 42 : Merck KGaA Life Sciences Segment: Revenue Share, by Segment, 2021
Figure 43 : Sartorius: Annual Revenue, 2019-2021
Figure 44 : Sartorius: Market Share, by Region, 2021
Figure 45 : Sartorius: Market Share, by Business Segment, 2021
Figure 46 : Thermo Fisher Scientific Inc.: Annual Revenue, 2019-2021
Figure 47 : Thermo Fisher Scientific Inc.: Market Share, by Region, 2021
Figure 48 : Thermo Fisher Scientific Inc.: Market Share, by Business Segment, 2021


    お問合せフォーム

    • レポートのタイトルは自動で入ります。
    • *のある項目は必須項目です。

    お名前*

    会社名*

    部署名

    メールアドレス*

    電話番号

    当ウェブサイトを知った経緯を教えてください。

    お問合せ内容

    株式会社SEMABIZ・ChosaReport.com プライバシーポリシー

    Eメールでのお問合せもお受けしております。
    下記アドレスへ“(at)”を“@”に変えてお送りください。通常1営業日以内にご返信いたします。
    crinquiry(at)chosareport.com